Long non-coding RNA XIST promotes the malignant features of oral squamous cell carcinoma (OSCC) cells through regulating miR-133a-5p/VEGFB
- PMID: 35912960
- DOI: 10.14670/HH-18-504
Long non-coding RNA XIST promotes the malignant features of oral squamous cell carcinoma (OSCC) cells through regulating miR-133a-5p/VEGFB
Abstract
Objective: Oral squamous cell carcinoma (OSCC) represents a frequently seen oral cavity malignancy, and the mechanisms of its occurrence and development remain unclear. The present work examined the expression and biological function of long non-coding RNA (lncNRA) XIST (X-inactive specific transcript) in OSCC cells and tissues.
Study design: A total number of 50 OSCC and paired non-carcinoma tissue samples were collected in this study. Gene expression levels in cancer tissues and cells were quantified by RT-qPCR. In addition, gain- and loss-of-function experiments were conducted to investigate the biological roles of XIST as well as its downstream targets in OSCC cells.
Results: XIST was upregulated in OSCC cells and tissues, which predicted a poorer prognostic outcome in OSCC patients. Silencing XIST inhibited the growth and invasion of OSCC cells and triggered apoptosis. miR-133a-5p was identified as a downstream target of XIST, which was downregulated in OSCC tissues. miR-133a-5p mediated the effect of XIST by targeting VEGFB. VEGFB overexpression rescued the inhibitory effects of XIST silencing on cell growth, invasion and migration.
Conclusion: Taken together, the above data indicates that XIST serves as an oncogenic factor to enhance the growth and invasion of OSCC cells by targeting the miR-133a/VEGFB axis.
©The Author(s) 2023. Open Access. This article is licensed under a Creative Commons CC-BY International License.
Similar articles
-
LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p.Oral Dis. 2023 May;29(4):1505-1512. doi: 10.1111/odi.14152. Epub 2022 Feb 27. Oral Dis. 2023. PMID: 35152529
-
LncRNA PVT1 promotes malignant progression by regulating the miR-7-5p/CDKL1 axis in oral squamous cell carcinoma.Mol Cell Probes. 2024 Dec;78:101995. doi: 10.1016/j.mcp.2024.101995. Epub 2024 Dec 2. Mol Cell Probes. 2024. PMID: 39617072
-
LncRNA DLEU1 facilitates the progression of oral squamous cell carcinoma by miR-126-5p/GAB1 axis.Kaohsiung J Med Sci. 2022 Oct;38(10):950-959. doi: 10.1002/kjm2.12572. Epub 2022 Aug 30. Kaohsiung J Med Sci. 2022. PMID: 36039933 Free PMC article.
-
A snapshot of miRNAs in oral squamous cell carcinoma: Difference between cancer cells and corresponding normal cells.Pathol Res Pract. 2023 Sep;249:154731. doi: 10.1016/j.prp.2023.154731. Epub 2023 Jul 29. Pathol Res Pract. 2023. PMID: 37573620 Review.
-
Emerging cell cycle related non-coding RNA biomarkers from saliva and blood for oral squamous cell carcinoma.Mol Biol Rep. 2023 Nov;50(11):9479-9496. doi: 10.1007/s11033-023-08791-w. Epub 2023 Sep 17. Mol Biol Rep. 2023. PMID: 37717257 Review.
Cited by
-
Pairwise analysis of gene expression for oral squamous cell carcinoma via a large-scale transcriptome integration.J Cell Mol Med. 2024 Oct;28(20):e70153. doi: 10.1111/jcmm.70153. J Cell Mol Med. 2024. PMID: 39470584 Free PMC article.
-
Identification of the differentially expressed activated memory CD4+ T-cells-related genes and ceRNAs in oral lichen planus.Heliyon. 2024 Jun 20;10(12):e33305. doi: 10.1016/j.heliyon.2024.e33305. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39022110 Free PMC article.
-
Survival prediction in patients with head and neck squamous cell carcinoma and novel mechanistic insights of S100A8/A9.Discov Oncol. 2024 Nov 15;15(1):657. doi: 10.1007/s12672-024-01540-w. Discov Oncol. 2024. PMID: 39546127 Free PMC article.
References
-
- Blot W.J., McLaughlin J.K., Winn D.M., Austin D.F., Greenberg R.S., Preston-Martin S., Bernstein L., Schoenberg J.B., Stemhagen A. and Fraumeni J.F. Jr. (1988). Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 48, 3282-3287. - PubMed
-
- Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A. and Jemal A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394-424. - PubMed
-
- Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M. and Croce C.M. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101, 2999-3004. - PMC - PubMed
-
- Chen G., Fang T., Huang Z., Qi Y., Du S., Di T., Lei Z., Zhang X. and Yan W. (2016). MicroRNA-133a inhibits osteosarcoma cells proliferation and invasion via targeting IGF-1R. Cell Physiol. Biochem. 38, 598-608. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical